BIOMAT Database Logo BIOMAT Database Logo

Anomeric specificity of glucose-induced somatostatin secretion. 1987

V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Laboratory of Experimental Medicine, Brussels Free University, Belgium.

In isolated perfused rat pancreases, the alpha-anomer of D-glucose is more potent than beta-D-glucose not solely in stimulating insulin release and suppressing glucagon output, but also in causing somatostatin secretion.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D011924 Rats, Zucker Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene. Zucker Rat,Zucker Rats,Rat, Zucker
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
[Anomeric specificity of glucose metabolism].
January 1988, Bulletin et memoires de l'Academie royale de medecine de Belgique,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Alteration of anomeric preference of glucose-induced insulin secretion by glyceraldehyde.
January 1993, Life sciences,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of glucose-induced insulin release in normal and diabetic subjects.
July 1987, Diabetes research (Edinburgh, Scotland),
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of enzymes of D-glucose metabolism.
March 1974, FEBS letters,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of D-glucose production by rat hepatocytes.
November 2004, Molecular and cellular biochemistry,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of D-glucose metabolism in rat adipocytes.
August 1986, European journal of biochemistry,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of human erythrocyte glucose-6-phosphate dehydrogenase.
July 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of D-glucose metabolism in human erythrocytes.
March 1988, Clinica chimica acta; international journal of clinical chemistry,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of glucose metabolism in health and disease.
January 2001, Acta clinica Belgica,
V Leclercq-Meyer, and M C Woussen-Colle, and C Lalieu, and J Marchand, and W J Malaisse
Anomeric specificity of glucose metabolism in the pentose cycle.
November 1985, The Journal of biological chemistry,
Copied contents to your clipboard!